SavedAdd your journal

Journals / MN Kardiyoloji / 2003 / Cilt: 10 - Sayı: 4

Clinical evaluation of the Sorin mechanical prosthesis

Sorin kalp kapak protezlerinin klinik değerlendirmesi

Mustafa ŞIRLAK
Raif Y. ÇAVOLLİ
Sadık ERYILMAZ
Levent YAZICIOĞLU
Uğursay KIZILTEPE
Ruçhan AKAR
Refik TAŞÖZ
Neyyir Tuncay EREN
Atila ARAL
Ümit ÖZYURDA
Pages
287–294
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In summary, either in early and late mortality or morbidity our overall experience with Sorin® mechanical bileaflet valves demonstraated satisfactory results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: In this study we presented our results of the use of Sorin® mechanical prosthesis in our clinic.
📊
Key Findings & Data:Material and Methods: Between 1995 and 2001, in Ankara University Cardiovascular Surgery Department 669 patients recived 796 Sorin® mechanical prosthesis.
💡
Conclusion & Impact:Conclusion: In summary, either in early and late mortality or morbidity our overall experience with Sorin® mechanical bileaflet valves demonstraated satisfactory results.
🔬Design:Research Article
📍Scope:2001 Verileri
⚙️Variables:Aort kapağı · Kalp cerrahi işlemleri · Kalp kapağı protezleri

Abstract

Aim: In this study we presented our results of the use of Sorin® mechanical prosthesis in our clinic. Material and Methods: Between 1995 and 2001, in Ankara University Cardiovascular Surgery Department 669 patients recived 796 Sorin® mechanical prosthesis. Of them 414 (%61.8) were in mitral position (MVR), 128 (%19.1) were in aortic position, and 127 (%19.0) were in mitral and aortic positions. Ages were ranging between 12 and 65 years (mean age 37.64±10.42 years). Result: Early mortality(postoperative first 30 days) were registered in 47 patients (early mortality rate was 7%, or without any additional procedures the mortality rate was 3.6%). There have been 27 late deaths (in total late mortality rate was 1.38 per 100 patient-years). In 87 patients valve related complications and valve dysfunctions were registered (4.33 per 100 patient-years). Conclusion: In summary, either in early and late mortality or morbidity our overall experience with Sorin® mechanical bileaflet valves demonstraated satisfactory results.

Özet

Amaç: Bu çalışmamızda yaygın olarak kullanılan kapak protezlerinden birisi olan "Sorin®" prostetik kalp kapağı ile 6 yıla varan deneyimlerimizin klinik sonuçlarını tartıştık. Gereç ve Yöntem: Ankara Üniversitesi Tıp fakültesi Kalp ve Damar Cerrahisi Anabilim Dalında 1995-2001 tarihleri arasında 6 yıllık sürede 669 hastaya toplam 796 Sorin® marka kalp kapağı implante edilmiştir. 414 (%61.8) hastaya mitral kapak replasmanı (MVR), 128 (%19.1) hastaya aort kapak replasmanı (AVR), 127 (%19.0) hastaya çift kapak replasmanı (DVR) uygulanmıştır. Global olarak Sorin® kapak replasmanı uygulanan hastaların yaşları 12 ile 65 arasında değişmekte idi. Ortalama yaş 37.64+10.42 olarak tespit edilmiştir. Bulgular: Erken dönem olarak adlandırılan ilk 30 günlük periodda 47 hasta kaybedilmiştir. Erken dönem mortalitesi global olarak %7.0, ek cerrahi girişimli vakaların hariç tutulduğu grupta ise %3.6 olarak hesaplanmıştır. 1963 hasta/yıllık takip sonunda geç dönemde 27 hasta kaybedilmiş ve geç dönem mortalite hızı %1.38 hasta/yıl olarak hesap edilmiştir. Çalışmamızda kapağa bağlı komplikasyonlar ve kapak disfonksiyonları 87 vakada görülmüş ve 1963 hasta/yıllık takip sonunda bu komplikasyonların linearize hızı %4.33 hasta/yıl olarak hesaplanmıştır. Sonuç: Sonuç olarak Sorin® kalp kapak protezi ile yapılan kalp kapak replasmanı sonrasında kısa ve uzun dönemde gerek mortalite ve gerekse morbidite açısından tatminkar klinik sonuçlar elde edilmiştir.

🔖

Cite This Article

ŞIRLAK, M., ÇAVOLLİ, R. Y., ERYILMAZ, S., YAZICIOĞLU, L., KIZILTEPE, U., AKAR, R., TAŞÖZ, R., EREN, N. T., ARAL, A., ÖZYURDA, Ü. (2003). Clinical evaluation of the Sorin mechanical prosthesis. MN Kardiyoloji, Cilt: 10 - Sayı: 4, 287–294. https://ajindex.com/articles/298026

References (14)

  1. Anderson RP, Bonchek LI, Grunkemeier GL, et al. The analysis and presentation of surgical results by acturial methods J Surg Res 1974; 16:224-30.
  2. Milano A, Bartolotti U, Mazzucco A, Guerra F, Magni A, Gallucci V. Aortic valve replacement with the Hancock standard, Björk-Shiley and Lillehei-Kaster prostheses: A comparison based on a comparison based on follow up from 1 to 15 years. J Thorac Cardiovasc Surg 1989; 98:37-47. Edmunds LH Jr. Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg 1987; 44:430-45.
  3. Milano A, Bartolotti U, Mazucco A, et al. Mitral valve replacement with the Hancock, Björk-Shiley and Lillehei-Kaster prostheses, a comparison based on a 15 year follow up. Eur J Cardiothorac Surg 1989; 3:312-20.
  4. Nitter-Hauge S, Abdelnoor M, Svennevig JL. Fifteen-year experience with the Medtronic-Hall valve prosthesis. Circulation 1996; 94:105-8.
  5. Duncan JM, Cooley DA, Reul GJ, et al. Durability and low trombogenicity of the St. Jude Medical valve at 5 years follow up. Ann Thorac Surg 1986; 42:500-5.
  6. Çobanoğlu A, FesslerCL, Güvendik L, Grunkemeier G, Starr A. Aortic valve replacement with Starr Edwards prosthesis: A comparison of the first and second decades of follow up. Ann Thorac Surg 1988; 45:248-52.
  7. Bortolotti U, Milano A, D' Alfonso A, et al. Evaluation of valve -related complications in patients with Sorin Bicarbon prosthesis: a seven-year experience. J Heart Valve Dis 2001; 10:795-801.
  8. Antunes JM, Wessels A, Sadowski R, et al. Medtronic Hall valve replacement in third world population group. J Thorac Cardiovasc Surg 1988; 95:980-93.
  9. Akalin H, Çorapçıoğlu T, Özyurda Ü, et al. Clinical evaluation of the Omniscience cardiac valve prosthesis: Follow up to 6 years. J Thorac Cardiovasc Surg 1992; 103:259-66.
  10. Keenan RJ, Armitage JM, Trento A, et al. Clinical experience with Medtronic Hall Valve Prosthesis. Ann Thorac Surg 1990; 50:753-84.
  11. Arom KV, Nicoloff DM, Kersten TE, et al. Ten years experience with St. Jude Medical valve prosthesis. Ann Thorac Surg 1989; 47:831-7. Antunes MJ. Clinical performance of St. Jude and Medtronic Hall prostheses: a randomized comparative study. Ann Thorac Surg 1990; 50:743-7.
  12. Soga Y, Okabayashi H, Nishina T, et al. Up to 8-Year Follow- up of valve replacement with Carbomedics valve. Ann Thorac Surg 2002; 73:474-9.
  13. Edwards MS, Russell GB, Edwards AF, et al. Results of valve replacement with Omniscience mechanical prostheses. Ann Thorac Surg 2002; 74:665-70.
  14. Gillinov AM, Faber CN, Sabik JF, et al.